
US President Donald Trump signed an executive order Saturday to accelerate review of psychedelic drugs including ibogaine, joined by podcaster Joe Rogan at the Oval Office event. The order aims to speed FDA approval processes for treatments addressing depression, PTSD, and other conditions. Advocacy groups have long sought expanded research into psychedelics' therapeutic potential.